Jordan has extensive experience working with entrepreneurs and growth companies as a venture investor and strategy consultant at Bain & Company and Cambridge Strategic Management Group. Since joining Kaiser Permanente Ventures in 2006, Jordan has focused on investments in diagnostics and imaging, ophthalmology and drug-delivery devices, and heath care information technology.
Jordan currently serves as a Board Observer to Agile Therapeutics, BDNA, Celula, Oxford Immunotec, Predictive Biosciences, and Transcend Medical.
Jordan holds a Bachelor's Degree in History from Cornell University and an international MBA in Entrepreneurial Studies and Finance from the University of Chicago Graduate School of Business.
Prior to joining Kaiser Permanente Ventures, Jordan spent three years as the Director of Finance and Development for BUILD, an educational non-profit using entrepreneurship to inspire at-risk high-school students to go to college. |